share_log
Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

Sonnet Biotherapeutics Hldgs Inc盘中异动 早盘快速下挫5.35%报1.77美元

自選股智能寫手 ·  09/27/2022 23:50

北京时间2022年09月27日23时03分,Sonnet Biotherapeutics Hldgs Inc(SONN.us)股票出现异动,股价急速下挫5.35%。截至发稿,该股报1.77美元/股,成交量11.3821万股,换手率2.63%,振幅5.88%。

最近的财报数据显示,该股实现营业收入62071.00美元,净利润-7.88百万美元,每股收益-1.82美元,毛利--,市盈率-0.28倍。

机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。

Sonnet Biotherapeutics Hldgs Inc股票所在的生物技术行业中,整体涨幅为2.42%。其相关个股中,Avenue Therapeutics Inc、Inmed Pharmaceuticals Inc、Bellerophon Therapeutics Inc涨幅较大,Avenue Therapeutics Inc、Inmed Pharmaceuticals Inc、Kiora Pharmaceuticals Inc较为活跃,换手率分别为2273.93%、493.06%、159.34%,振幅较大的相关个股有Avenue Therapeutics Inc、Inmed Pharmaceuticals Inc、Surrozen Inc C/Wts 01/08/2031 (To Pur Com),振幅分别为157.95%、65.56%、42.13%。

Sonnet Biotherapeutics Hldgs Inc公司简介:Sonnet BioTherapeutics Holdings Inc是一家临床阶段的生物制药公司。该公司开发的FHAB(Fully Human Albumin Binding)技术非常适合在一系列人类疾病领域进行药物开发,包括在肿瘤、自身免疫、致病性、炎症和血液病领域。公司的管线产品包括SON-080(低剂量IL-6)、SON-1210(IL15- FHAB-IL12)、SON-1010(IL12-FHAB)等。

(以上内容为自选股智能机器写手Money Call完成,仅作为用户看盘参考,不作为交易依据。)

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.